CTLA4 (N-term) Rabbit Polyclonal Antibody
CAT#: AP52146PU-N
CTLA4 (N-term) rabbit polyclonal antibody, Aff - Purified
Need it in bulk or conjugated?
Get a free quote
CNY 6,160.00
Cited in 4 publications. |
Specifications
Product Data | |
Applications | IHC, WB |
Recommend Dilution | Western Blot: 1/2000. Immunohistochemistry on Paraffin Sections: 1/50-1/100. |
Reactivity | Human |
Host | Rabbit |
Clonality | Polyclonal |
Immunogen | KLH conjugated synthetic peptide between 50-78 amino acids from the N-terminal region of Human CD152 / CTLA4. |
Specificity | This antibody recognizes Human CD152 / CTLA4 (N-term). |
Formulation | PBS State: Aff - Purified State: Liquid purified Ig fraction Preservative: 0.09% Sodium Azide |
Concentration | lot specific |
Purification | Affinity Chromatography on Protein A |
Conjugation | Unconjugated |
Storage Condition | Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. |
Gene Name | cytotoxic T-lymphocyte associated protein 4 |
Database Link | |
Background | CTLA4 is a member of the immunoglobulin superfamily and encodes a protein which transmits an inhibitory signal to T cells. The protein contains a V domain, a transmembrane domain, and a cytoplasmic tail. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. The membrane-bound isoform functions as a homodimer interconnected by a disulfide bond, while the soluble isoform functions as a monomer. Mutations in this gene have been associated with insulin-dependent diabetes mellitus, Graves disease, Hashimoto thyroiditis, celiac disease, systemic lupus erythematosus, thyroid-associated orbitopathy, and other autoimmune diseases. |
Synonyms | CTLA-4 |
Reference Data | |
Protein Families | Druggable Genome, Transmembrane |
Protein Pathways | Autoimmune thyroid disease, Cell adhesion molecules (CAMs), T cell receptor signaling pathway |
Citations (4)
The use of this Antibodies has been cited in the following citations: |
---|
An immunohistochemical analysis of CD3, PD-L1, and CTLA-4 expression in carcinosarcomas of the gynecological tract and their metastases
,Karpathiou, G;Chauleur, C;Dal Col, P;Dridi, M;Hathroubi, S;Mobarki, M;Peoc'h, M;,
Pathology - Research and Practice
[CTLA4]
|
The immune checkpoints CTLA-4 and PD-L1 in carcinomas of the uterine cervix
,Karpathiou, G;Chauleur, C;Mobarki, M;Peoc'h, M;,
Pathol. Res. Pract.
,PubMed ID 31862202
[CTLA4]
|
Expression of CD3, PD-L1 and CTLA-4 in mammary and extra-mammary Paget disease
,Karpathiou, G;Chauleur, C;Hathroubi, S;Habougit, C;Peoc'h, M;,
Cancer Immunol. Immunother.
,PubMed ID 29943071
[CTLA4]
|
Prognostic impact of immune microenvironment in laryngeal and pharyngeal squamous cell carcinoma: Immune cell subtypes, immuno-suppressive pathways and clinicopathologic characteristics
,Karpathiou, G;Casteillo, F;Giroult, JB;Forest, F;Fournel, P;Monaya, A;Froudarakis, M;Dumollard, JM;Prades, JM;Peoc'h, M;,
Oncotarget
,PubMed ID 28038471
[CTLA4]
|
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |